Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice
Xinjun Lu, Baogang Peng, Ge Chen, et al.
American Journal Of Pathology (2021) Vol. 191, Iss. 9, pp. 1651-1667
Open Access | Times Cited: 15

Showing 15 citing articles:

Hippo signalling in the liver: role in development, regeneration and disease
Jacquelyn O. Russell, Fernando D. Camargo
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 5, pp. 297-312
Open Access | Times Cited: 131
Geroscience and pathology: a new frontier in understanding age-related diseases
Mónika Fekete, Dávid Major, Ágnes Fehér, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 30
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy
Yuting Gao, Yi Gong, Junlan Lu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma
Sungjin Ko, Minwook Kim, Laura Molina, et al.
Advances in cancer research (2022), pp. 283-317
Open Access | Times Cited: 11
Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma
Xinjun Lu, Benjamin L. Green, Changqing Xie, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100723-100723
Open Access | Times Cited: 4
Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis
Chao Zhang, Chengkun Qin
Human Cell (2024) Vol. 37, Iss. 3, pp. 739-751
Closed Access | Times Cited: 1
IGF2 mediates Hippo signaling to control liver size
Zhenxing Zhong, Ruxin Jin, Ying Zhong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
Chaobo Chen, Hanghang Wu, Hui Ye, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 4
Untargeted UPLC-MS-based metabolomics analysis reveals the metabolic profile of intrahepatic cholangiocarcinoma process and the intervention effect of Osthole in mice
Xin Chen, Haisong Liu, Lei Shen, et al.
Pharmacological Research - Modern Chinese Medicine (2022) Vol. 3, pp. 100096-100096
Open Access | Times Cited: 3
The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma
Mete Ucdal, Ayşe Buruş, Başak Çeltikçi
International Journal of Hepatobiliary and Pancreatic Diseases (2024) Vol. 14, Iss. 2, pp. 1-14
Open Access
Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1
Wenbo Ma, Jinqiang Zhang, Weina Chen, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 19, Iss. 1, pp. 101417-101417
Open Access
The Molecular Pathogenesis and Targeted Therapies for Cholangiocarcinoma
Nesteene J. Param, Emily R. Bramel, Daniela Sia
Surgical pathology clinics (2022) Vol. 15, Iss. 3, pp. 529-539
Closed Access | Times Cited: 1
Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis
S. A. Klemm, Katja Evert, Kirsten Utpatel, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access
Untargeted UPLC-Ms-Based Metabolomics Analysis Reveals the Metabolic Profile of Intrahepatic Cholangiocarcinoma Process and the Intervention Effect of Osthole in Mice
Xin Chen, Haisong Liu, Lei Shen, et al.
SSRN Electronic Journal (2021)
Closed Access
Page 1

Scroll to top